Together. For A Cure. Now. Alzheimer's Research UK launched a powerful new film to highlight the importance of dementia ...

Research has found that people who led an active lifestyle, especially before 50 years old, had better brain health aged 70.

READ-OUT is a new study underway trialling different types of blood tests in different groups of people across the UK ...

Gavin Patterson joins Alzheimer's Research UK as chair. The former President and Chief Revenue Officer of Salesforce and CEO ...

Walk For A Cure is back for 2025 and this year, Alzheimer’s Research UK will be hosting walks at eight exciting locations across the UK. In 2024, we were proud to have 3,386 participants join our ...

If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team! There’s no minimum sponsorship target and we can provide help and ...

FREE entry for Maverick 50km Ultra Marathons, when you fundraise £250. If you already have a place in this event but would like to support Alzheimer’s Research UK, we’d love to have you on the team!

All applications for funds are reviewed by the Organising Committee, with conflicts of interest appropriately managed. New opportunities for 2025 Pump Priming awards, Equipment and Travel Awards will ...

Alzheimer’s Research UK has a large number of different grant schemes through which you can apply for funding. All applications must fall within Alzheimer’s Research UK’s remit which covers biomedical ...

A great event to walk off the Christmas celebrations, and to kick start your New Year fitness regime! There are Full Marathon, Half Marathon & 10K options, both starting & finishing at The Oval ...

The Brain Tour, inside dementia is an app designed for iOS and Android phones, that uses augmented reality to transport users inside the brain. Whether you're curious to explore a healthy brain or ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...